| Date | Title | Description |
| 02.09.2025 | ExpreS2ion Biotech Highlights CEO Presentations at Økonomisk Ugebrev and ProHearings Investor Events | ExpreS2ion Biotech Highlights CEO Presentations at Økonomisk Ugebrev and ProHearings Investor Events
Tue, Sep 02, 2025 11:00 CET Report this content
Hørsholm, Denmark, 2 September 2025 – ExpreS2ion Biotech Holding AB’s (“ExpreS2ion” or the ... |
| 27.08.2025 | ExpreS2ion Biotech Announces Analysguiden Publishes Updated Equity Research Report; Price Target Maintained at SEK 75 | ExpreS2ion Biotech Announces Analysguiden Publishes Updated Equity Research Report; Price Target Maintained at SEK 75
Wed, Aug 27, 2025 15:15 CET Report this content
Hørsholm, Denmark, 27 August 2025 – ExpreS2ion Biotech Holding AB’s affili... |
| 21.08.2025 | ExpreS2ion Biotech Announces Pareto Securities Analyst Note on Q2 2025 Results; Buy Rating Maintained with Price Target at SEK 303 | ExpreS2ion Biotech Announces Pareto Securities Analyst Note on Q2 2025 Results; Buy Rating Maintained with Price Target at SEK 303
Thu, Aug 21, 2025 14:00 CET Report this content
Hørsholm, Denmark, 21 August 2025 – ExpreS2ion Biotech Holdin... |
| 24.06.2025 | ExpreS2ion Biotech Announces Pareto Securities Analyst Note on First Patient Dosed in Phase I Trial | ExpreS2ion Biotech Announces Pareto Securities Analyst Note on First Patient Dosed in Phase I Trial
Tue, Jun 24, 2025 16:15 CET Report this content
Hørsholm, Denmark, 24 June 2025 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biote... |
| 28.05.2025 | Bulletin from the Annual General Meeting of Expres2ion Biotech Holding AB held on 28 May 2025 | Bulletin from the Annual General Meeting of Expres2ion Biotech Holding AB held on 28 May 2025
Wed, May 28, 2025 11:30 CET Report this content
The Annual General Meeting 2025 (the "AGM") of ExpreS2ion Biotech Holding AB ("Expr... |
| 23.05.2025 | ExpreS2ion Biotech Announces Analysguiden Publishes Equity Research Report | ExpreS2ion Biotech Announces Analysguiden Publishes Equity Research Report
Fri, May 23, 2025 13:29 CET Report this content
Hørsholm, Denmark, 23 May 2025 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2io... |
| 21.05.2025 | ExpreS2ion Biotech Announces Pareto Securities Analyst Update on Q1 2025 Results and Clinical Trial Progress | ExpreS2ion Biotech Announces Pareto Securities Analyst Update on Q1 2025 Results and Clinical Trial Progress
Wed, May 21, 2025 11:13 CET Report this content
Hørsholm, Denmark, 21 May 2025 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2i... |
| 01.05.2025 | ExpreS2ion annual report for 2024 published | ExpreS2ion annual report for 2024 published
Thu, May 01, 2025 12:40 CET Report this content
Hørsholm, Denmark, 1 May 2025 - ExpreS2ion Biotech Holding AB (“ExpreS2ion”) announces that the Annual Report for the financial year 2024 has been p... |
| 12.12.2024 | ExpreS2ion Biotech: A Promising Horizon in Cancer Treatment | ExpreS2ion Biotech Holding AB is making waves in the biotechnology sector. The company, based in Hørsholm, Denmark, is on a mission to revolutionize vaccine development. Recently, it announced significant financial movements and clinical ad... |
| 11.12.2024 | Analysguiden Publishes Research Report on ExpreS2ion Biotech with Price Target of SEK 91 | Analysguiden Publishes Research Report on ExpreS2ion Biotech with Price Target of SEK 91
Wed, Dec 11, 2024 10:00 CET Report this content
Hørsholm, Denmark, 11 December 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnolog... |
| 02.12.2024 | ExpreS2ion publishes video presentations from Biostock Life Science Summit and Analysguiden Stora Aktiedagarna | ExpreS2ion publishes video presentations from Biostock Life Science Summit and Analysguiden Stora Aktiedagarna
Mon, Dec 02, 2024 12:45 CET Report this content
Hørsholm, Denmark, 2 December 2024 – ExpreS2ion Biotech Holding AB’s subsidiary E... |
| 02.12.2024 | Last day of trading in warrants of series TO 10 in Expres2ion Biotech Holding AB is today, 2 December 2024 | Last day of trading in warrants of series TO 10 in Expres2ion Biotech Holding AB is today, 2 December 2024
Mon, Dec 02, 2024 09:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIREC... |
| 21.11.2024 | ExpreS2ion Biotechnologies: Full commitments from members of ExpreS2ion's Board and Management holding warrants of series TO 10 | ExpreS2ion Biotechnologies: Full commitments from members of ExpreS2ion's Board and Management holding warrants of series TO 10
Thu, Nov 21, 2024 08:45 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART... |
| 20.11.2024 | ExpreS2ion Biotechnologies: ExpreS2ion announces the start of the exercise period for warrants of series TO 10 | ExpreS2ion Biotechnologies: ExpreS2ion announces the start of the exercise period for warrants of series TO 10
Wed, Nov 20, 2024 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR IND... |
| 15.11.2024 | ExpreS2ion and Evaxion: A New Dawn for CMV Vaccines | In the world of biotechnology, breakthroughs often feel like whispers in a storm. Yet, the recent collaboration between ExpreS2ion Biotech and Evaxion Biotech is a thunderclap. Their joint effort focuses on a vaccine for cytomegalovirus (CM... |
| 14.11.2024 | ExpreS2ion announces TO 10 warrant exercise price and start of exercise period | ExpreS2ion announces TO 10 warrant exercise price and start of exercise period
Thu, Nov 14, 2024 19:47 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED... |
| 21.10.2024 | Bulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ) | Bulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB (publ)
Mon, Oct 21, 2024 11:00 CET Report this content
Today, on 21 October 2024, ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company&qu... |
| 23.08.2024 | ExpreS2ion announces publication of sponsored research reports | ExpreS2ion announces publication of sponsored research reports
Fri, Aug 23, 2024 12:45 CET Report this content
Hørsholm, Denmark, 23 August 2024 – ExpreS2ion Biotech Holding AB (Nasdaq First North Growth Market: EXPRS2) is pleased to announ... |
| 26.06.2024 | Rights issue subscription period ending 27 June 2024; subscription possible via form | Rights issue subscription period ending 27 June 2024; subscription possible via form
Wed, Jun 26, 2024 09:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE ... |
| 18.06.2024 | ExpreS2ion hosts informative webinar on 2024 Rights Issue and Highlights Key Updates on HER2+ Breast Cancer Vaccine | ExpreS2ion hosts informative webinar on 2024 Rights Issue and Highlights Key Updates on HER2+ Breast Cancer Vaccine
Tue, Jun 18, 2024 13:00 CET Report this content
Hørsholm, Denmark, 18 June 2024 – ExpreS2ion Biotech Holding AB’s ("Exp... |
| 12.06.2024 | The subscription period in ExpreS2ion’s rights issue begins today | The subscription period in ExpreS2ion’s rights issue begins today
Wed, Jun 12, 2024 08:45 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUST... |
| 10.06.2024 | ExpreS2ion to present in upcoming investor and scientific events | ExpreS2ion to present in upcoming investor and scientific events
Mon, Jun 10, 2024 14:00 CET Report this content
Hørsholm, Denmark, 10 June 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") ... |
| 05.06.2024 | ExpreS2ion publishes prospectus in connection with its rights issue of units | ExpreS2ion publishes prospectus in connection with its rights issue of units
Wed, Jun 05, 2024 16:40 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED S... |
| 08.05.2024 | ExpreS2ion annual report for 2023 published | ExpreS2ion annual report for 2023 published
Wed, May 08, 2024 12:05 CET Report this content
Hørsholm, Denmark, 8 May 2024 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby announces that the company's annual report for the financial yea... |
| 04.12.2023 | Pareto Securities publishes research report | Pareto Securities publishes research report
Mon, Dec 04, 2023 09:01 CET Report this content
Hørsholm, Denmark, 4 December 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that Par... |
| 27.11.2023 | ExpreS2ion CEO interviewed, CFO provides update at life science investor conference, Analysguiden publishes research report | ExpreS2ion CEO interviewed, CFO provides update at life science investor conference, Analysguiden publishes research report
Mon, Nov 27, 2023 13:30 CET Report this content
Hørsholm, Denmark, 27 November 2023 – ExpreS2ion Biotech Holding AB’... |
| 18.09.2023 | Last day of trading in warrants of series TO 8 in Expres2ion Biotechnologies is today, 18 September 2023 | Last day of trading in warrants of series TO 8 in Expres2ion Biotechnologies is today, 18 September 2023
Mon, Sep 18, 2023 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTL... |
| 13.09.2023 | ExpreS2ion’s Board, CEO and CFO commit to full exercise of their series TO 8 warrants | ExpreS2ion’s Board, CEO and CFO commit to full exercise of their series TO 8 warrants
Wed, Sep 13, 2023 09:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE... |
| 07.09.2023 | ExpreS2ion announces the start of the exercise period for warrants of series TO 8 | ExpreS2ion announces the start of the exercise period for warrants of series TO 8
Thu, Sep 07, 2023 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNI... |
| 04.09.2023 | ExpreS2ion announces TO 8 warrant exercise price and start of exercise period | ExpreS2ion announces TO 8 warrant exercise price and start of exercise period
Mon, Sep 04, 2023 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED ... |
| 02.05.2023 | ExpreS2ion - Annual report for 2022 published | ExpreS2ion - Annual report for 2022 published
Tue, May 02, 2023 13:35 CET Report this content
Hørsholm, Denmark, 2 May 2023 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby announces that the company's annual report for the financial y... |
| 11.04.2023 | ExpreS2ion publishes video presentation | ExpreS2ion publishes video presentation
Tue, Apr 11, 2023 11:00 CET Report this content
Hørsholm, Denmark, 11 April 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed ... |
| 11.04.2023 | Rights issue subscription period ending 12 April 2023; subscription possible via form | Rights issue subscription period ending 12 April 2023; subscription possible via form
Tue, Apr 11, 2023 12:15 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE... |
| 16.03.2023 | Pareto and Analysguiden publish research reports | Pareto and Analysguiden publish research reports
Thu, Mar 16, 2023 18:00 CET Report this content
Hørsholm, Denmark, 16 March 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that ... |
| 03.03.2023 | Notice to Extraordinary General Meeting in ExpreS2ion Biotech Holding AB | Notice to Extraordinary General Meeting in ExpreS2ion Biotech Holding AB
Fri, Mar 03, 2023 20:53 CET Report this content
N.B. This notice has been prepared in both Swedish and English language versions. In the event of any discrepancies bet... |
| 18.11.2022 | Pareto and Analysguiden publish research reports with SEK 25 per share price targets and ExpreS2ion publishes third quarter financial report video presentation | Pareto and Analysguiden publish research reports with SEK 25 per share price targets and ExpreS2ion publishes third quarter financial report video presentation
Fri, Nov 18, 2022 10:30 CET Report this content
Hørsholm, Denmark, November 18, ... |
| 13.06.2022 | Analysguiden publishes research report setting price target of SEK 30 with an optimistic fair value of SEK 60 | Analysguiden publishes research report setting price target of SEK 30 with an optimistic fair value of SEK 60
Mon, Jun 13, 2022 10:00 CET Report this content
Hørsholm, Denmark, June 13, 2022 – ExpreS2ion Biotech Holding AB’s affiliate Expre... |
| 01.06.2022 | ExpreS2ion publishes video presentation | ExpreS2ion publishes video presentation
Wed, Jun 01, 2022 13:15 CET Report this content
Hørsholm, Denmark, June 1, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed c... |
| 04.05.2022 | ExpreS2ion - Annual report for 2021 published | ExpreS2ion - Annual report for 2021 published
Wed, May 04, 2022 12:13 CET Report this content
Hørsholm, Denmark, May 04, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) hereby announces that the company's annual report for the financial... |
| 20.04.2022 | ExpreS2ion publishes video presentation | ExpreS2ion publishes video presentation
Wed, Apr 20, 2022 10:06 CET Report this content
Hørsholm, Denmark, April 20, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that a filmed... |
| 13.04.2022 | ExpreS2ion publishes prospectus in connection with fully guaranteed rights issue of approximately SEK 73 million | ExpreS2ion publishes prospectus in connection with fully guaranteed rights issue of approximately SEK 73 million
Wed, Apr 13, 2022 11:15 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR I... |
| 08.04.2022 | Pareto Securities publishes research report revising price target to SEK 86 | Pareto Securities publishes research report revising price target to SEK 86
Fri, Apr 08, 2022 12:00 CET Report this content
Hørsholm, Denmark, April 8, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS... |
| 15.03.2022 | ExpreS2ion publishes video from company presentation at Aktiespararna’s Aktiedagen | ExpreS2ion publishes video from company presentation at Aktiespararna’s Aktiedagen
Tue, Mar 15, 2022 14:34 CET Report this content
Hørsholm, Denmark, March 15, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS ... |
| 09.03.2022 | Analysguiden publishes research report setting new price target of SEK 39 with an optimistic fair value of at least SEK 80 | Analysguiden publishes research report setting new price target of SEK 39 with an optimistic fair value of at least SEK 80
Wed, Mar 09, 2022 09:35 CET Report this content
Hørsholm, Denmark, March 9, 2022 – ExpreS2ion Biotech Holding AB’s af... |
| 01.03.2022 | Pareto publishes research report increasing price target to SEK 99 | Pareto publishes research report increasing price target to SEK 99
Tue, Mar 01, 2022 11:15 CET Report this content
Hørsholm, Denmark, March 1, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion"... |
| 09.12.2021 | Pareto Securities and Analysguiden publish research reports; Pareto increases price target to SEK 79 | Pareto Securities and Analysguiden publish research reports; Pareto increases price target to SEK 79 Thu, Dec 09, 2021 12:53 CET
Hørsholm, Denmark, December 9, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS ... |
| 19.11.2021 | Pareto Securities and Analysguiden publish research reports; Analysguiden increases price target to SEK 60 | Pareto Securities and Analysguiden publish research reports; Analysguiden increases price target to SEK 60 Fri, Nov 19, 2021 11:05 CET
Hørsholm, Denmark, November 19, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologi... |
| 10.09.2021 | Last day of trading in warrants of series TO5 is September 16, 2021 | Last day of trading in warrants of series TO5 is September 16, 2021 Fri, Sep 10, 2021 08:30 CET
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HON... |
| 25.08.2021 | Pareto Securities and Analysguiden publish research reports with increased price targets of SEK 68 and SEK 55, respectively | Pareto Securities and Analysguiden publish research reports with increased price targets of SEK 68 and SEK 55, respectively Wed, Aug 25, 2021 16:16 CET
Hørsholm, Denmark, August 25, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2io... |
